Table 1 Clinical and laboratory characteristics of patients with peripheral artery disease (PAD group) and controls (CO group) at baseline
PAD group (n=168) | CO group (n=74) | P value | |
|---|---|---|---|
Age (y) | 76 ± 11 | 70 ± 10 | 0.223 |
Males, n (%) | 141 (83.9) | 60 (81) | 0.929 |
Smoking, n (%) | 43 (25.6) | 13 (17.6) | < 0.001 |
Hypertension, n (%) | 125 (74.4) | 13 (17.6) | < 0.001 |
Dyslipidemia, n (%) | 162 (96.4) | 35 (47.3) | < 0.001 |
Statins, n (%) | 160 (95.2) | 19 (25.7) | < 0.001 |
ABI | 0.48 (0.09) | 1.1 (0.1) | < 0.001 |
Diabetes, n (%) | 68 (36.9) | 7 (9.5) | < 0.001 |
BMI (kg/m2) | 27.98 ± 3.22 | 26.9 ± 4.32 | 0.212 |
SBP (mmHg) | 139 ± 21 | 125 ± 12 | < 0.001 |
DBP (mmHg) | 85 ± 9 | 78 ± 8 | 0.405 |
Creatinine (mg/dl) | 1.61 ± 0.4 | 1.1 ± 0.3 | 0.112 |
TChol (mg/dl) | 183 ± 54 | 162 ± 41 | 0.105 |
HDL-C (mg/dl) | 41 ± 8 | 49 ± 13 | 0.013 |
LDL-C (mg/dl) | 117 ± 43 | 92 ± 22 | 0.072 |
TG (mg/dl) | 122 ± 64 | 106 ± 33 | 0.199 |
FPG (mg/dl) | 145 ± 35 | 100 ± 17 | < 0.001 |
HbA1c (%)a | 7.3 ± 1.4 | – | – |
WBC (cells/µL) | 10,984 ± 2998 | 6234 ± 2109 | < 0.001 |
hsCRP (mg/L) | 7.64 ± 2.26 | 1.12 ± 0.42 | < 0.001 |
RBP-4 (mg/L) | 43.33 ± 18.88 | 15.11 ± 4.45 | < 0.001 |
Adiponectin (mg/L) | 6.53 ± 2.45 | 12.33 ± 2.1 | < 0.001 |